Overview
Dr. Jitendra Singh, Union Minister of State (Independent Charge) for Science & Technology, announced two landmark steps on 16 July 2026: the launch of India’s first Engineering Biology graduation programme and a roadmap to make India a global bioeconomy leader by 2035.
Key Developments
- Introduction of a dedicated Engineering Biology degree, the first of its kind in the country.
- Release of the "Building India as a Leading Bioeconomy Powerhouse by 2035" roadmap.
- Commitment to a ₹50,000 crore Bioeconomy Growth Fund to boost talent, infrastructure and industry partnerships.
- Emphasis on Synthetic Biology, AI‑enabled biology and bio‑manufacturing as future drivers.
- Highlight of India’s achievements: world’s first DNA vaccine against COVID‑19 and supply to ~30 countries.
Important Facts
The bioeconomy has grown from about USD 10 billion in 2014 to USD 95 billion in 2026. Projections show it could reach USD 300 billion by 2030 and USD 700 billion by 2035. India now hosts over 11,000 biotechnology start‑ups, more than 10,000 biotech companies, and around 100 bio‑incubators. Annual growth rates are estimated at 15‑18 %, contributing roughly 4.8 % to GDP.
The roadmap is backed by the BioE3 Policy, which aims to translate research into commercial products quickly.
Exam Relevance
Understanding the bioeconomy links directly to GS III topics such as industrial policy, innovation ecosystems, and health security. The push for Synthetic Biology and AI‑enabled biology illustrates how emerging technologies reshape traditional sectors, a recurring theme in GS III and GS IV ethics questions on responsible innovation.
Policy instruments like the BioE3 Policy and the proposed ₹50,000 crore Bioeconomy Growth Fund provide case studies for questions on fiscal measures, public‑private partnerships and skill development.
Way Forward
To realise the roadmap, the government must:
- Scale indigenous bio‑manufacturing capacities through incentives and regulatory clarity.
- Strengthen the talent pipeline by expanding interdisciplinary curricula like Engineering Biology across IITs and medical institutes.
- Foster deeper industry‑academia collaboration, especially in areas such as DNA vaccine production, CAR‑T cell therapy and gene‑based treatments.
- Leverage AI tools to accelerate research, reduce costs and ensure ethical deployment.
Successful implementation will not only boost health security and food sustainability but also generate millions of high‑skill jobs, positioning India as a leading global biotechnology hub.